Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
132
NCT01224639
Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 11, 2010
Completion: Nov 9, 2011
NCT01376479
Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71
Start: Aug 31, 2011
Completion: Apr 30, 2012